Home › Anthony Yu

Anthony Yu, Pharm.D., M.S.

Director, Health Economics and Outcomes Research

Anthony Yu, Pharm.D., M.S., partners with life sciences organizations to deliver real-world epidemiologic and health outcomes analyses across a range of therapeutic areas.

Prior to joining Inovalon, Anthony completed a postdoctoral HEOR fellowship at Baylor Scott & White Health (BSWH), where he led industry-sponsored studies, supported research initiatives within the organization’s accountable care organization and outpatient antibiotic stewardship committee, and conducted independent research using electronic health record and claims data to evaluate the real-world value of healthcare interventions.

His research has focused on disease burden, patient journeys, treatment utilization, and clinical and economic outcomes. Anthony has authored or co-authored 15 conference abstracts and has six scholarly manuscripts pending publication.

Anthony holds a Doctor of Pharmacy and a Bachelor of Science in Pharmacy Studies from Northeastern University, as well as a Master of Science in Pharmaceutical Sciences (Health Outcomes Track) from the University of Texas at Austin.

Connect on LinkedIn

Authored Content

Hematology, oncology

A Comparative Assessment of Travel Burden and Productivity Loss for CAR T-Cell Therapy and Bispecific Antibody Treatment in Patients With Relapsed/Refractory LBCL Using U.S. Claims Data

Accepted for presentation at International Society for Pharmacoeconomics and Outcomes Research. Findings available upon request. Contact us for more information.

Epilepsy

Examining the Impact of Comorbid Depression on Healthcare Utilization, Cost, and Outcomes in Patients With Newly Diagnosed Epilepsy in the U.S.

Accepted for presentation at American Academy of Neurology. Findings available upon request. Contact us for more information.

Epilepsy

Impact of Depression on Outcomes and Treatment Patterns in Patients With Newly Diagnosed Epilepsy: A Retrospective Claims Analysis

Accepted for presentation at American Epilepsy Society. Findings available upon request. Contact us for more information.

Oncology

The Association Between Average Sales Price Decline and Shortages in Small Molecule Injectable Oncology Therapies With Generic Competition

Accepted for presentation at International Society of Pharmacoeconomics and Outcomes Research Europe. Findings available upon request. Contact us for more information.